Advisors Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $402K | Buy |
|
|||||
|
2025
Q1 | $299K | Buy |
|
|||||
|
2024
Q4 | $241K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $415K | Sell |
|
|||||
|
2023
Q2 | $508K | Sell |
|
|||||
|
2023
Q1 | $522K | Sell |
|
|||||
|
2022
Q4 | $482K | Sell |
|
|||||
|
2022
Q3 | $648K | Sell |
|
|||||
|
2022
Q2 | $706K | Sell |
|
|||||
|
2022
Q1 | $1.47M | Buy |
|
|||||
|
2021
Q4 | $1.4M | Buy |
|
|||||
|
2021
Q3 | $985K | Sell |
|
|||||
|
2021
Q2 | $940K | Sell |
|
|||||
|
2021
Q1 | $1.1M | Sell |
|
|||||
|
2020
Q4 | $730K | Buy |
|
|||||
|
2020
Q3 | $559K | Buy |
|
|||||
|
2020
Q2 | $435K | Buy |
|
|||||
|
2020
Q1 | $251K | Sell |
|
|||||
|
2019
Q4 | $568K | Sell |
|
|||||
|
2019
Q3 | $628K | Sell |
|
|||||
|
2019
Q2 | $1.03M | Sell |
|
|||||
|
2019
Q1 | $1.18M | Sell |
|
|||||
|
2018
Q4 | $1.3M | Buy |
|
|||||
|
2018
Q3 | $2.36M | Buy |
|
|||||
|
2018
Q2 | $1.33M | Buy |
|
|||||
|
2018
Q1 | $559K | Buy |
|
|||||
|
2017
Q4 | $467K | Buy |
|
|||||
|
2017
Q3 | $327K | Buy |
|